NewAmsterdam Pharma Co N.V. (NAMS) earnings
Quarterly results of NewAmsterdam Pharma Co N.V. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
NewAmsterdam Pharma Co N.V. was expected to report around November 4, 2026; nothing is on file with the SEC yet.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended September 30, 2026) NewAmsterdam Pharma Co N.V. reported revenue of $19.2M (+5,406.9% on the same quarter a year earlier) and a net loss of $17.4M.
Diluted earnings per share were -$0.14.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | $19.2M | +5,406.9% | -$17.4M | -$0.14 |
| Q2 FY2026 | $3.7M | -80.7% | -$64.1M | -$0.52 |
| Q1 FY2026 | $3M | +2.1% | -$48.4M | -$0.40 |
| Q4 FY2025 | $32K | -99.7% | -$74.9M | - |
| Q3 FY2025 | $348K | - | -$72M | -$0.61 |
| Q2 FY2025 | $19.1M | - | -$17.4M | -$0.15 |
| Q1 FY2025 | $3M | - | -$39.5M | -$0.34 |
| Q4 FY2024 | $12.8M | - | -$92.2M | - |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
When is NewAmsterdam Pharma Co N.V.'s next earnings date?
NewAmsterdam Pharma Co N.V. was expected to report around November 4, 2026; nothing is on file with the SEC yet.
What were NewAmsterdam Pharma Co N.V.'s latest quarterly results?
For Q3 FY2026, which ended September 30, 2026, NewAmsterdam Pharma Co N.V. reported revenue of $19.2M and a net loss of $17.4M. The figures come from its filing with the SEC.
Is NewAmsterdam Pharma Co N.V.'s revenue growing?
Revenue in Q3 FY2026 was $19.2M, up 5,406.9% from $348K in the same quarter a year earlier.
Get an email when NAMS reports
Follow NAMS and we email you its next results the day they are filed, with the numbers explained.